Document is current

Any future updates will be listed below

Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting—its impact on clinical practice

Crossref DOI link: https://doi.org/10.1186/s13045-015-0183-8

Published Online: 2015-07-28

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark